| Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance DA Fidock, T Nomura, AK Talley, RA Cooper, SM Dzekunov, MT Ferdig, ... Molecular cell 6 (4), 861-871, 2000 | 1822 | 2000 |
| A molecular marker for chloroquine-resistant falciparum malaria A Djimdé, OK Doumbo, JF Cortese, K Kayentao, S Doumbo, Y Diourté, ... New England journal of medicine 344 (4), 257-263, 2001 | 1248 | 2001 |
| Antimalarial drug discovery: efficacy models for compound screening DA Fidock, PJ Rosenthal, SL Croft, R Brun, S Nwaka Nature reviews Drug discovery 3 (6), 509-520, 2004 | 1157 | 2004 |
| Spiroindolones, a potent compound class for the treatment of malaria M Rottmann, C McNamara, BKS Yeung, MCS Lee, B Zou, B Russell, ... science 329 (5996), 1175-1180, 2010 | 1147 | 2010 |
| Malaria: progress, perils, and prospects for eradication BM Greenwood, DA Fidock, DE Kyle, SHI Kappe, PL Alonso, FH Collins, ... The Journal of clinical investigation 118 (4), 1266-1276, 2008 | 988 | 2008 |
| Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations ABS Sidhu, D Verdier-Pinard, DA Fidock Science 298 (5591), 210-213, 2002 | 949 | 2002 |
| K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates J Straimer, NF Gnädig, B Witkowski, C Amaratunga, V Duru, ... Science 347 (6220), 428-431, 2015 | 721 | 2015 |
| Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria RT Eastman, DA Fidock Nature Reviews Microbiology 7 (12), 864-874, 2009 | 626 | 2009 |
| Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil DA Fidock, TE Wellems Proceedings of the National Academy of Sciences 94 (20), 10931-10936, 1997 | 582 | 1997 |
| A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms D Ménard, N Khim, J Beghain, AA Adegnika, M Shafiul-Alam, O Amodu, ... New England Journal of Medicine 374 (25), 2453-2464, 2016 | 512 | 2016 |
| Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic B Blasco, D Leroy, DA Fidock Nature medicine 23 (8), 917-928, 2017 | 494 | 2017 |
| Decreasing pfmdr1 Copy Number in Plasmodium falciparum Malaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and Artemisinin ABS Sidhu, AC Uhlemann, SG Valderramos, JC Valderramos, S Krishna, ... The Journal of infectious diseases 194 (4), 528-535, 2006 | 485 | 2006 |
| Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda A Uwimana, E Legrand, BH Stokes, JLM Ndikumana, M Warsame, ... Nature medicine 26 (10), 1602-1608, 2020 | 458 | 2020 |
| pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum ABS Sidhu, SG Valderramos, DA Fidock Molecular microbiology 57 (4), 913-926, 2005 | 454 | 2005 |
| Targeting Plasmodium PI(4)K to eliminate malaria CW McNamara, MCS Lee, CS Lim, SH Lim, J Roland, A Nagle, O Simon, ... Nature 504 (7479), 248-253, 2013 | 413 | 2013 |
| A novel multiple-stage antimalarial agent that inhibits protein synthesis B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ... Nature 522 (7556), 315-320, 2015 | 397 | 2015 |
| Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine … RA Cooper, MT Ferdig, XZ Su, LMB Ursos, J Mu, T Nomura, H Fujioka, ... Molecular pharmacology 61 (1), 35-42, 2002 | 348 | 2002 |
| Artemisinin action and resistance in Plasmodium falciparum L Tilley, J Straimer, NF Gnädig, SA Ralph, DA Fidock Trends in parasitology 32 (9), 682-696, 2016 | 344 | 2016 |
| Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery S Meister, DM Plouffe, KL Kuhen, GMC Bonamy, T Wu, SW Barnes, ... Science 334 (6061), 1372-1377, 2011 | 343 | 2011 |
| Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data MR Kuo, HR Morbidoni, D Alland, SF Sneddon, BB Gourlie, MM Staveski, ... Journal of Biological Chemistry 278 (23), 20851-20859, 2003 | 336 | 2003 |
